Emil Achmad1, Takeshi Yokoo1,2, Gavin Hamilton1, Elhamy R Heba1, Jonathan C Hooker1, Christopher Changchien1, Michael Schroeder1, Tanya Wolfson3, Anthony Gamst3, Jeffrey B Schwimmer1,4,5, Joel E Lavine6, Claude B Sirlin1, Michael S Middleton7,8. 1. Liver Imaging Group, Department of Radiology, School of Medicine, University of California, San Diego, San Diego, CA, USA. 2. Department of Radiology and Advanced Imaging Research Center, UT Southwestern School of Medicine, Dallas, TX, USA. 3. Computational and Applied Statistics Laboratory (CASL), San Diego Supercomputing Center (SDSC), University of California, San Diego, San Diego, CA, USA. 4. Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, School of Medicine, University of California, San Diego, San Diego, CA, USA. 5. Department of Gastroenterology, Rady Children's Hospital San Diego, San Diego, CA, USA. 6. Department of Pediatrics, Columbia University, New York, NY, USA. 7. Liver Imaging Group, Department of Radiology, School of Medicine, University of California, San Diego, San Diego, CA, USA. msm@ucsd.edu. 8. UCSD Department of Radiology, UCSD MRI Institute, 410 West Dickinson Street, San Diego, CA, 92103-8749, USA. msm@ucsd.edu.
Abstract
PURPOSE: To assess feasibility of and agreement between magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) for estimating hepatic proton density fat fraction (PDFF) in children with known or suspected nonalcoholic fatty liver disease (NAFLD). MATERIALS AND METHODS: Children were included in this study from two previous research studies in each of which three MRI and three MRS acquisitions were obtained. Sequence acceptability, and MRI- and MRS-estimated PDFF were evaluated. Agreement of MRI- with MRS-estimated hepatic PDFF was assessed by linear regression and Bland-Altman analysis. Age, sex, BMI-Z score, acquisition time, and artifact score effects on MRI- and MRS-estimated PDFF agreement were assessed by multiple linear regression. RESULTS: Eighty-six children (61 boys and 25 girls) were included in this study. Slope and intercept from regressing MRS-PDFF on MRI-PDFF were 0.969 and 1.591%, respectively, and the Bland-Altman bias and 95% limits of agreement were 1.17% ± 2.61%. MRI motion artifact score was higher in boys than girls (by 0.21, p = 0.021). Higher BMI-Z score was associated with lower agreement between MRS and MRI (p = 0.045). CONCLUSION: Hepatic PDFF estimation by both MRI and MRS is feasible, and MRI- and MRS-estimated PDFF agree closely in children with known or suspected NAFLD.
PURPOSE: To assess feasibility of and agreement between magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) for estimating hepatic proton density fat fraction (PDFF) in children with known or suspected nonalcoholic fatty liver disease (NAFLD). MATERIALS AND METHODS:Children were included in this study from two previous research studies in each of which three MRI and three MRS acquisitions were obtained. Sequence acceptability, and MRI- and MRS-estimated PDFF were evaluated. Agreement of MRI- with MRS-estimated hepatic PDFF was assessed by linear regression and Bland-Altman analysis. Age, sex, BMI-Z score, acquisition time, and artifact score effects on MRI- and MRS-estimated PDFF agreement were assessed by multiple linear regression. RESULTS: Eighty-six children (61 boys and 25 girls) were included in this study. Slope and intercept from regressing MRS-PDFF on MRI-PDFF were 0.969 and 1.591%, respectively, and the Bland-Altman bias and 95% limits of agreement were 1.17% ± 2.61%. MRI motion artifact score was higher in boys than girls (by 0.21, p = 0.021). Higher BMI-Z score was associated with lower agreement between MRS and MRI (p = 0.045). CONCLUSION: Hepatic PDFF estimation by both MRI and MRS is feasible, and MRI- and MRS-estimated PDFF agree closely in children with known or suspected NAFLD.
Entities:
Keywords:
MRI; MRS; NAFLD; PDFF; Proton density fat fraction; Steatosis
Authors: Sarah M Lindbäck; Charles Gabbert; Benjamin L Johnson; Emmanuil Smorodinsky; Claude B Sirlin; Natalie Garcia; Perrie E Pardee; Kristin D Kistler; Jeffrey B Schwimmer Journal: Adv Pediatr Date: 2010
Authors: Geraldine H Kang; Irene Cruite; Masoud Shiehmorteza; Tanya Wolfson; Anthony C Gamst; Gavin Hamilton; Mark Bydder; Michael S Middleton; Claude B Sirlin Journal: J Magn Reson Imaging Date: 2011-07-18 Impact factor: 4.813
Authors: Hannah I Awai; Kimberly P Newton; Claude B Sirlin; Cynthia Behling; Jeffrey B Schwimmer Journal: Clin Gastroenterol Hepatol Date: 2013-09-30 Impact factor: 11.382
Authors: Gary J Cowin; Julie R Jonsson; Judith D Bauer; Susan Ash; Azmat Ali; Emma J Osland; David M Purdie; Andrew D Clouston; Elizabeth E Powell; Graham J Galloway Journal: J Magn Reson Imaging Date: 2008-10 Impact factor: 4.813
Authors: Aaron Sodickson; Pieter F Baeyens; Katherine P Andriole; Luciano M Prevedello; Richard D Nawfel; Richard Hanson; Ramin Khorasani Journal: Radiology Date: 2009-04 Impact factor: 11.105
Authors: Camilo A Campo; Diego Hernando; Tilman Schubert; Candice A Bookwalter; Andrew J Van Pay; Scott B Reeder Journal: AJR Am J Roentgenol Date: 2017-07-13 Impact factor: 3.959
Authors: Yingzhen N Zhang; Kathryn J Fowler; Gavin Hamilton; Jennifer Y Cui; Ethan Z Sy; Michelle Balanay; Jonathan C Hooker; Nikolaus Szeverenyi; Claude B Sirlin Journal: Br J Radiol Date: 2018-06-06 Impact factor: 3.039
Authors: Michael S Middleton; Mark L Van Natta; Elhamy R Heba; Adina Alazraki; Andrew T Trout; Prakash Masand; Elizabeth M Brunt; David E Kleiner; Edward Doo; James Tonascia; Joel E Lavine; Wei Shen; Gavin Hamilton; Jeffrey B Schwimmer; Claude B Sirlin Journal: Hepatology Date: 2018-01-26 Impact factor: 17.425
Authors: Emir Tas; Shasha Bai; Xiawei Ou; Kelly Mercer; Haixia Lin; Kori Mansfield; Robert Buchmann; Eva C Diaz; Jon Oden; Elisabet Børsheim; Sean H Adams; Jonathan Dranoff Journal: Front Endocrinol (Lausanne) Date: 2020-09-17 Impact factor: 5.555